Insidious Greed: How Big Pharma Rips You Off on Drugs

8

Click here to load reader

description

As long as Big Pharma is allowed to operate this stunningly predatory business model, helpless Americans will continue getting ripped off by Big Pharma.

Transcript of Insidious Greed: How Big Pharma Rips You Off on Drugs

Page 1: Insidious Greed: How Big Pharma Rips You Off on Drugs

IN$IDEOUS GREEDHow Big Pharma Rips You Off on Drugs

spent on marketing to doctors$20 BILLION

spent on generic pay-for-delay

$3.5 BILLION

spent on dtc advertising

$3.8 BILLIONdrug sales profits$3OO BILLION

$3.4 BILLION

$226 MILLION

spent on industry events & conventions

*Follow Big Pharma’s “Per Year” Billion Dollar Spending Spree.

spent on lobbying in 2013

Page 3: Insidious Greed: How Big Pharma Rips You Off on Drugs

IN$IDEOUS GREED$226 MILLION

In 2013 Big Pharma spent $226 million, considerably more than military contractors spent on lobbying. In addition, drug firms use their political influence to gain an advantage.

The industry gave an unprecedented $50 million on political candidates in 2012, earning Big Pharma the title of the largest contributor to political campaigns . . . ever.

*Follow Big Pharma’s “Per Year” Billion Dollar Spending Spree.

<<< TWEET IF YOU CARE!TWEET IF YOU CARE! >>>

Page 4: Insidious Greed: How Big Pharma Rips You Off on Drugs

IN$IDEOUS GREED$3.5 BILLION

Another scheme called “Pay-for-Delay” costs an estimated 3.5 Billion a year involves Big Pharma paying the makers of generic versions to hold off on their development, raking in obscene amounts of money for both parties.

Yet again, patients are stuck with obscene prices. In Europe, this is illegal. In the U.S., however, Big Pharma has successfully lobbied against legislation that would ban the practice.

*Follow Big Pharma’s “Per Year” Billion Dollar Spending Spree.

TWEET IF YOU CARE! >>> <<< TWEET IF YOU CARE!

Page 7: Insidious Greed: How Big Pharma Rips You Off on Drugs

IN$IDEOUS GREED$300 BILLION

According to the World Health Organization, the global pharmaceuticals market is worth $300 billion a year, a figure expected to rise to US$400 billion within three years.

As a result of this pressure to maintain sales, there is now, in WHO's words, “an inherent conflict of interest between the legitimate business goals of manufacturers and the social, medical and economic needs of providers and the public to select and use drugs in the most rational way”.

*Follow Big Pharma’s “Per Year” Billion Dollar Spending Spree.

TWEET IF YOU CARE! >>> <<< TWEET IF YOU CARE!